Skip to main content
. 2014 Aug 25;64(2):383–392. doi: 10.2337/db14-0765

Table 1.

Demographics and metabolic measurements

Type 1 diabetes (n = 21) Control (n = 17)
Sex (male) 10 (47.6) 5 (29.4)
Age (years) 15.0 (13.0, 18.0) 14.0 (12.0, 18.0)
Race**
 White 18 (85.7) 9 (52.9)
 Hispanic 3 (14.3) 4 (23.5)
 Black 0 2 (11.8)
 Other (more than one) 0 2 (11.8)
Tanner stage*
 Missing 1 (4.8) 0
 2 0 3 (17.7)
 3 1 (4.8) 0
 4 4 (19.1) 7 (41.2)
 5 15 (71.4) 7 (41.2)
BMI (kg/m2)** 25.0 ± 4.2 21.4 ± 3.9
Waist-to-hip ratio 0.9 ± 0.1 0.8 ± 0.1
Percent total body muscle mass 65.9 ± 9.8 68.3 ± 8.8
HbA1c (%)*** 8.2 (6.7, 12.0) 5.3 (4.7, 5.8)
HbA1c (mmol/mol)*** 66 (50, 108) 34 (28, 40)
Inflammatory markers
 AST (units/L) 28.5 (19.0, 45.0) 29.0 (18.0, 62.0)
 ALT (units/L) 20.0 (3.0, 38.0) 19.5 (12.0, 64.0)
 hs-CRP (mg/L) 0.49 (0.12, 7.71) 0.20 (0.03, 20.60)
 Interleukin-6 (pg/mL) 1.25 (1.25, 12.50) 1.25 (1.25, 11.90)
 Myloperoxidase (mg/L) 445.0 ± 193.7 433.7 ± 173.2
 White blood cells (1 kcell/μg) 6.2 (3.9, 14.3) 5.8 (3.4, 7.8)
 Platelets (1 kcell/μg) 240.7 ± 57.6 251.1 ± 51.2
Lipids
 Total cholesterol (mg/dL)** 140.2 ± 24.9 163.2 ± 26.6
 Triglycerides (mg/dL) 74.0 (42.0, 112.0) 83.0 (44.0, 196.0)
 HDL (mg/dL) 47.1 ± 9.2 46.8 ± 10.9
 LDL (mg/dL)* 78.5 ± 20.7 98.9 ± 26.1
 FFA baseline (mmol/L)* 355.8 ± 226.3 563.9 ± 212.1
Clamp measurements
 FFA end clamp (mmol/L)* 33.0 (7.5, 125.0) 20.5 (15.0, 35.0)
 Insulin end clamp (mmol/L) 181.0 (108.0, 812.0) 213.3 (158.0, 252.0)
 Glucose end clamp (mg/dL) 94.7 ± 4.7 99.1 ± 9.4
 GIR (mg/kglean/min)*** 10.10 (3.01, 20.78) 18.92 (9.39, 28.09)
Rd (mg/kglean/min)*** 12.3 ± 4.4 19.9 ± 3.9

Data are n (%), mean ± SD, or median (minimum, maximum). P values are from χ2 or Fisher exact test, t test, or Kruskal-Wallis test, as appropriate.

*0.01 ≤ P ≤ 0.05;

**0.0001 ≤ P < 0.01;

***P < 0.0001. kcell, representing 1,000 cells.